Wednesday, August 10, 2022

Serum Institute to begin phase 3 trials of Covid-19 vaccine soon 

Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.

As per the official statement of the Sassoon General Hospital, currently, volunteer registration is going on for the trials. Earlier the testing of Covid 19 vaccine by the Serum Institute of Inida was paused as per the orders by the DGGI.  The institute is set to begin the testing of III phase now, a statement issued by the institute said.

The statement said that the Phase III of Covishield Vaccine trial has been started in Sassoon General Hospital, Pune. It said that at present, volunteer registration was going on for that, those who were willing to volunteer for vaccination could contact on the following numbers–8550960196, 8104201267.

Also read: NIA arrests 9 terrorists with links to Al-Qaeda in multiple raids from Kerala, West Bengal

Also read: With Akalis set to oppose the farm bills, Govt reaches out to friendly parties as RS numbers look uncertain

On September 16, ANI reported that the Drugs Controller General of India (DCGI) has allowed the Serum Institute of India to restart its phase two and three clinical trials for the Covishield Vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSMB), UK and DSMB India and requested permission to restart enrolment in the subject clinical trial of the vaccine.

Also read: Defence, security aspect of India-Japan relationship has progressed fast: S Jaishankar

Latest news

Related news